Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma

Daniel A. Ermann; Victoria A. Vardell; Erin Hickey; Amanda Fegley; Dipenkumar Modi; Kalub Fedak; Suchitra Sundaram Sundaram; Sridevi Rajeeve; Gaurav Goyal; Haris Hatic; Pallawi Torka; Sheeba Ba Aqeel; Azra Borogovac; Kira MacDougall; Shalin Kothari; Anna Kress; Elizabeth Travers; Nitin Chilakamarri; Elizabeth Brém; Sabarish Ayyappan; Audrey M. Sigmund; David A. Bond; Lindsey Fitzgerald; Charlotte B Wagner; Boyu Hu; Deborah M. Stephens; Harsh Shah

doi:10.1016/j.clml.2026.01.018

Key Points

Novel chemotherapy regimens improve clinical outcomes in relapsed Hodgkin lymphoma compared to traditional options, enhancing treatment possibilities.
A significant finding shows a higher response rate with novel therapies at 80% versus 55% in traditional regimens.
Observational analysis across multiple clinical sites highlights the varying effectiveness of chemotherapy regimens in Hodgkin lymphoma patients.
These findings support the need for personalized treatment approaches, as choices can greatly impact patient outcomes.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Comparison reveals clinical outcomes of novel versus traditional chemotherapy regimens for relapsed Hodgkin lymphoma, suggesting effectiveness variations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ermann et al. (2026) studied this question.

synapsesocial.com/papers/69a765f4badf0bb9e87db0d7 https://doi.org/10.1016/j.clml.2026.01.018

View at Publisher

Ask AI

Bookmark

Share

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading